{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:04:48Z","timestamp":1782961488430,"version":"3.54.5"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,6,4]],"date-time":"2012-06-04T00:00:00Z","timestamp":1338768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00408-012-9393-9","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T04:53:29Z","timestamp":1347944009000},"page":"579-581","source":"Crossref","is-referenced-by-count":12,"title":["Improvements in Cystic Fibrosis Lung Disease and Airway Inflammation Associated with Etanercept Therapy for Rheumatoid Arthritis: A Case Report"],"prefix":"10.1007","volume":"190","author":[{"given":"S.","family":"Visser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Serisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,4]]},"reference":[{"key":"9393_CR1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","volume":"168","author":"RL Gibson","year":"2003","unstructured":"Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168:918\u2013951","journal-title":"Am J Respir Crit Care Med"},{"key":"9393_CR2","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","volume":"183","author":"M Cohen-Cymberknoh","year":"2011","unstructured":"Cohen-Cymberknoh M, Shoseyov D, Kerem E (2011) Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am J Respir Crit Care Med 183:1463\u20131471","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 28","key":"9393_CR3","first-page":"125","volume":"40","author":"MW Konstan","year":"2005","unstructured":"Konstan MW, Doring G, Lands LC et al (2005) Results of a phase II clinical trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of CF lung disease. Pediatr Pulmonol 40(Suppl 28):125","journal-title":"Pediatr Pulmonol"},{"key":"9393_CR4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO (2004) Granulomatous infectious diseases associated with tumour necrosis factor antagonists. Clin Infect Dis 38:1261\u20131265","journal-title":"Clin Infect Dis"},{"key":"9393_CR5","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1002\/art.23050","volume":"56","author":"JR Curtis","year":"2007","unstructured":"Curtis JR, Xi J, Patkar N et al (2007) Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumour necrosis factor antagonists. Arthritis Rheum 56:4226","journal-title":"Arthritis Rheum"},{"key":"9393_CR6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00408-009-9138-6","volume":"187","author":"B Casserly","year":"2009","unstructured":"Casserly B, Donat W (2009) Stabilization of lung function and clinical symptoms in a patient with cystic fibrosis (CF) after institution of infliximab: a monoclonal antibody that binds tumour necrosis factor alpha. Lung 187:149\u2013152","journal-title":"Lung"},{"issue":"15","key":"9393_CR7","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3748\/wjg.v16.i15.1924","volume":"16","author":"F Vincenzi","year":"2010","unstructured":"Vincenzi F, Bizzarri B, Ghiselli A, de Angelis N, Fornaroli F, de Angelis GL (2010) Cystic fibrosis and Crohn\u2019s disease: successful treatment and long term remission with infliximab. World J Gastroenterol 16(15):1924\u20131927","journal-title":"World J Gastroenterol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-012-9393-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-012-9393-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-012-9393-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T14:37:53Z","timestamp":1559054273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-012-9393-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,4]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["9393"],"URL":"https:\/\/doi.org\/10.1007\/s00408-012-9393-9","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,4]]}}}